nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—Statin Pathway—SOAT1—atherosclerosis	0.0644	0.113	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOC1—atherosclerosis	0.0488	0.0857	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—PLTP—atherosclerosis	0.0296	0.0519	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—ABCG8—atherosclerosis	0.0256	0.045	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—LCAT—atherosclerosis	0.0191	0.0335	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—ABCG8—atherosclerosis	0.0187	0.0329	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOA4—atherosclerosis	0.0187	0.0329	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—CYP7A1—atherosclerosis	0.0184	0.0323	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOA2—atherosclerosis	0.0161	0.0283	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—ABCG5—atherosclerosis	0.0159	0.0279	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOA5—atherosclerosis	0.0147	0.0259	CbGpPWpGaD
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—LIPC—atherosclerosis	0.0142	0.0249	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—LIPC—atherosclerosis	0.0122	0.0214	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOC3—atherosclerosis	0.0121	0.0213	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—LDLR—atherosclerosis	0.0121	0.0212	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—CETP—atherosclerosis	0.0118	0.0207	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—ABCG5—atherosclerosis	0.0116	0.0204	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—SCARB1—atherosclerosis	0.0113	0.0198	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—HMGCR—atherosclerosis	0.0106	0.0187	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—ABCA1—atherosclerosis	0.00949	0.0167	CbGpPWpGaD
Icosapent ethyl—VIIth nerve paralysis—Lovastatin—atherosclerosis	0.00911	0.0226	CcSEcCtD
Icosapent ethyl—DGAT1—Triacylglyceride Synthesis—LPL—atherosclerosis	0.00866	0.0152	CbGpPWpGaD
Icosapent ethyl—VIIth nerve paralysis—Simvastatin—atherosclerosis	0.00852	0.0212	CcSEcCtD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—SCARB1—atherosclerosis	0.00823	0.0144	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOB—atherosclerosis	0.0078	0.0137	CbGpPWpGaD
Icosapent ethyl—VIIth nerve paralysis—Pravastatin—atherosclerosis	0.00771	0.0192	CcSEcCtD
Icosapent ethyl—Icosapent—TRPV1—atherosclerosis	0.00761	0.381	CrCbGaD
Icosapent ethyl—DGAT1—Statin Pathway—LPL—atherosclerosis	0.00745	0.0131	CbGpPWpGaD
Icosapent ethyl—Alpha-Linolenic Acid—TRPV1—atherosclerosis	0.00743	0.372	CrCbGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—PLA2G2A—atherosclerosis	0.00663	0.0116	CbGpPWpGaD
Icosapent ethyl—Faecal incontinence—Niacin—atherosclerosis	0.00636	0.0158	CcSEcCtD
Icosapent ethyl—DGAT1—Statin Pathway—APOE—atherosclerosis	0.00624	0.011	CbGpPWpGaD
Icosapent ethyl—DGAT1—Statin Pathway—APOA1—atherosclerosis	0.00617	0.0108	CbGpPWpGaD
Icosapent ethyl—DGAT1—Glycerophospholipid biosynthesis—PLA2G1B—atherosclerosis	0.00583	0.0102	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—LPL—atherosclerosis	0.00543	0.00954	CbGpPWpGaD
Icosapent ethyl—Generalised oedema—Niacin—atherosclerosis	0.0054	0.0134	CcSEcCtD
Icosapent ethyl—Enlargement abdomen—Niacin—atherosclerosis	0.00534	0.0133	CcSEcCtD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CD36—atherosclerosis	0.00516	0.00907	CbGpPWpGaD
Icosapent ethyl—Cough increased—Rosuvastatin—atherosclerosis	0.00482	0.012	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PLA2G2A—atherosclerosis	0.00462	0.00812	CbGpPWpGaD
Icosapent ethyl—Laryngitis—Niacin—atherosclerosis	0.00445	0.0111	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CYP7A1—atherosclerosis	0.00427	0.00749	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PLA2G1B—atherosclerosis	0.00407	0.00715	CbGpPWpGaD
Icosapent ethyl—Viral infection—Ezetimibe—atherosclerosis	0.00406	0.0101	CcSEcCtD
Icosapent ethyl—Cataract—Lovastatin—atherosclerosis	0.00393	0.00976	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA2—atherosclerosis	0.00374	0.00656	CbGpPWpGaD
Icosapent ethyl—Neck pain—Ezetimibe—atherosclerosis	0.00371	0.00922	CcSEcCtD
Icosapent ethyl—Cataract—Simvastatin—atherosclerosis	0.00367	0.00913	CcSEcCtD
Icosapent ethyl—Gastroenteritis—Rosuvastatin—atherosclerosis	0.00361	0.00898	CcSEcCtD
Icosapent ethyl—DGAT1—connective tissue—atherosclerosis	0.0036	0.434	CbGeAlD
Icosapent ethyl—Cough increased—Niacin—atherosclerosis	0.00351	0.00872	CcSEcCtD
Icosapent ethyl—Viral infection—Pravastatin—atherosclerosis	0.0035	0.0087	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA5—atherosclerosis	0.00342	0.006	CbGpPWpGaD
Icosapent ethyl—Cataract—Pravastatin—atherosclerosis	0.00332	0.00825	CcSEcCtD
Icosapent ethyl—Eructation—Niacin—atherosclerosis	0.00315	0.00784	CcSEcCtD
Icosapent ethyl—Fluid retention—Niacin—atherosclerosis	0.00305	0.00758	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00291	0.00511	CbGpPWpGaD
Icosapent ethyl—Eczema—Simvastatin—atherosclerosis	0.00282	0.00702	CcSEcCtD
Icosapent ethyl—Arthritis—Lovastatin—atherosclerosis	0.00279	0.00694	CcSEcCtD
Icosapent ethyl—Influenza—Rosuvastatin—atherosclerosis	0.00277	0.00688	CcSEcCtD
Icosapent ethyl—DGAT1—adipose tissue—atherosclerosis	0.00276	0.333	CbGeAlD
Icosapent ethyl—Arthritis—Ezetimibe—atherosclerosis	0.00274	0.00681	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00273	0.0048	CbGpPWpGaD
Icosapent ethyl—Pancreatitis—Rosuvastatin—atherosclerosis	0.00271	0.00674	CcSEcCtD
Icosapent ethyl—Bronchitis—Rosuvastatin—atherosclerosis	0.00266	0.00661	CcSEcCtD
Icosapent ethyl—Arthritis—Simvastatin—atherosclerosis	0.00261	0.00649	CcSEcCtD
Icosapent ethyl—Eczema—Niacin—atherosclerosis	0.00259	0.00645	CcSEcCtD
Icosapent ethyl—Icosapent—PPARG—atherosclerosis	0.00253	0.126	CrCbGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—HMGCR—atherosclerosis	0.00247	0.00434	CbGpPWpGaD
Icosapent ethyl—Arthritis—Niacin—atherosclerosis	0.0024	0.00596	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.0024	0.00596	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00237	0.00416	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00237	0.00416	CbGpPWpGaD
Icosapent ethyl—Arthritis—Pravastatin—atherosclerosis	0.00236	0.00587	CcSEcCtD
Icosapent ethyl—Gastritis—Ezetimibe—atherosclerosis	0.00236	0.00585	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00235	0.00583	CcSEcCtD
Icosapent ethyl—Influenza—Lovastatin—atherosclerosis	0.00235	0.00583	CcSEcCtD
Icosapent ethyl—Sinusitis—Rosuvastatin—atherosclerosis	0.00232	0.00575	CcSEcCtD
Icosapent ethyl—Influenza—Ezetimibe—atherosclerosis	0.0023	0.00572	CcSEcCtD
Icosapent ethyl—Pancreatitis—Lovastatin—atherosclerosis	0.0023	0.00572	CcSEcCtD
Icosapent ethyl—Migraine—Niacin—atherosclerosis	0.00229	0.0057	CcSEcCtD
Icosapent ethyl—Affect lability—Pravastatin—atherosclerosis	0.00226	0.00561	CcSEcCtD
Icosapent ethyl—Pancreatitis—Ezetimibe—atherosclerosis	0.00226	0.00561	CcSEcCtD
Icosapent ethyl—Gastritis—Simvastatin—atherosclerosis	0.00225	0.00558	CcSEcCtD
Icosapent ethyl—Rhinitis—Rosuvastatin—atherosclerosis	0.00222	0.00552	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—atherosclerosis	0.0022	0.00387	CbGpPWpGaD
Icosapent ethyl—Pharyngitis—Rosuvastatin—atherosclerosis	0.0022	0.00546	CcSEcCtD
Icosapent ethyl—Mood swings—Pravastatin—atherosclerosis	0.00217	0.0054	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Lovastatin—atherosclerosis	0.00216	0.00537	CcSEcCtD
Icosapent ethyl—Pancreatitis—Simvastatin—atherosclerosis	0.00215	0.00535	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00212	0.00527	CcSEcCtD
Icosapent ethyl—Bronchitis—Simvastatin—atherosclerosis	0.00211	0.00524	CcSEcCtD
Icosapent ethyl—Infestation—Ezetimibe—atherosclerosis	0.00205	0.0051	CcSEcCtD
Icosapent ethyl—Infestation NOS—Ezetimibe—atherosclerosis	0.00205	0.0051	CcSEcCtD
Icosapent ethyl—Abdominal distension—Niacin—atherosclerosis	0.00203	0.00504	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00202	0.00503	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Simvastatin—atherosclerosis	0.00202	0.00502	CcSEcCtD
Icosapent ethyl—Influenza—Niacin—atherosclerosis	0.00201	0.00501	CcSEcCtD
Icosapent ethyl—Dysphagia—Niacin—atherosclerosis	0.00201	0.00501	CcSEcCtD
Icosapent ethyl—Abdominal distension—Pravastatin—atherosclerosis	0.002	0.00496	CcSEcCtD
Icosapent ethyl—Influenza—Pravastatin—atherosclerosis	0.00198	0.00493	CcSEcCtD
Icosapent ethyl—Arrhythmia—Rosuvastatin—atherosclerosis	0.00198	0.00492	CcSEcCtD
Icosapent ethyl—Angina pectoris—Niacin—atherosclerosis	0.00196	0.00488	CcSEcCtD
Icosapent ethyl—Sinusitis—Lovastatin—atherosclerosis	0.00196	0.00488	CcSEcCtD
Icosapent ethyl—Pancreatitis—Pravastatin—atherosclerosis	0.00194	0.00483	CcSEcCtD
Icosapent ethyl—Bronchitis—Niacin—atherosclerosis	0.00194	0.00481	CcSEcCtD
Icosapent ethyl—DGAT1—liver—atherosclerosis	0.00194	0.233	CbGeAlD
Icosapent ethyl—Angina pectoris—Pravastatin—atherosclerosis	0.00193	0.0048	CcSEcCtD
Icosapent ethyl—Sinusitis—Ezetimibe—atherosclerosis	0.00192	0.00478	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00187	0.00329	CbGpPWpGaD
Icosapent ethyl—Erectile dysfunction—Niacin—atherosclerosis	0.00186	0.00461	CcSEcCtD
Icosapent ethyl—Sinusitis—Simvastatin—atherosclerosis	0.00184	0.00456	CcSEcCtD
Icosapent ethyl—Pharyngitis—Ezetimibe—atherosclerosis	0.00183	0.00454	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Pravastatin—atherosclerosis	0.00183	0.00454	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.00176	0.00309	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.00176	0.00309	CbGpPWpGaD
Icosapent ethyl—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00174	0.00433	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Pravastatin—atherosclerosis	0.00173	0.00431	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00173	0.00304	CbGpPWpGaD
Icosapent ethyl—Sweating—Niacin—atherosclerosis	0.00172	0.00428	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.0017	0.00298	CbGpPWpGaD
Icosapent ethyl—Chills—Lovastatin—atherosclerosis	0.00168	0.00419	CcSEcCtD
Icosapent ethyl—Cough—Rosuvastatin—atherosclerosis	0.00168	0.00418	CcSEcCtD
Icosapent ethyl—Sinusitis—Pravastatin—atherosclerosis	0.00166	0.00412	CcSEcCtD
Icosapent ethyl—Alopecia—Lovastatin—atherosclerosis	0.00166	0.00412	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—atherosclerosis	0.00164	0.00288	CbGpPWpGaD
Icosapent ethyl—Myalgia—Rosuvastatin—atherosclerosis	0.00164	0.00408	CcSEcCtD
Icosapent ethyl—Arthralgia—Rosuvastatin—atherosclerosis	0.00164	0.00408	CcSEcCtD
Icosapent ethyl—Alopecia—Ezetimibe—atherosclerosis	0.00163	0.00404	CcSEcCtD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CG—atherosclerosis	0.00162	0.00284	CbGpPWpGaD
Icosapent ethyl—Rhinitis—Niacin—atherosclerosis	0.00162	0.00402	CcSEcCtD
Icosapent ethyl—Malnutrition—Ezetimibe—atherosclerosis	0.0016	0.00398	CcSEcCtD
Icosapent ethyl—Dysgeusia—Lovastatin—atherosclerosis	0.0016	0.00398	CcSEcCtD
Icosapent ethyl—Rhinitis—Pravastatin—atherosclerosis	0.00159	0.00396	CcSEcCtD
Icosapent ethyl—Back pain—Lovastatin—atherosclerosis	0.00158	0.00393	CcSEcCtD
Icosapent ethyl—Pharyngitis—Pravastatin—atherosclerosis	0.00158	0.00392	CcSEcCtD
Icosapent ethyl—Chills—Simvastatin—atherosclerosis	0.00158	0.00392	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00157	0.00276	CbGpPWpGaD
Icosapent ethyl—Infection—Rosuvastatin—atherosclerosis	0.00156	0.00389	CcSEcCtD
Icosapent ethyl—Alopecia—Simvastatin—atherosclerosis	0.00155	0.00386	CcSEcCtD
Icosapent ethyl—Back pain—Ezetimibe—atherosclerosis	0.00155	0.00385	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atherosclerosis	0.00153	0.00268	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Lovastatin—atherosclerosis	0.00152	0.00377	CcSEcCtD
Icosapent ethyl—Dysgeusia—Simvastatin—atherosclerosis	0.0015	0.00372	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00149	0.00261	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00149	0.00261	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00149	0.00261	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00149	0.00261	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00149	0.0037	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—atherosclerosis	0.00148	0.0026	CbGpPWpGaD
Icosapent ethyl—Malaise—Lovastatin—atherosclerosis	0.00147	0.00366	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00147	0.00258	CbGpPWpGaD
Icosapent ethyl—Vertigo—Lovastatin—atherosclerosis	0.00147	0.00365	CcSEcCtD
Icosapent ethyl—Chills—Niacin—atherosclerosis	0.00145	0.0036	CcSEcCtD
Icosapent ethyl—Malaise—Ezetimibe—atherosclerosis	0.00145	0.00359	CcSEcCtD
Icosapent ethyl—Arrhythmia—Niacin—atherosclerosis	0.00144	0.00358	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00143	0.00356	CcSEcCtD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—atherosclerosis	0.00143	0.00252	CbGpPWpGaD
Icosapent ethyl—Alopecia—Niacin—atherosclerosis	0.00142	0.00354	CcSEcCtD
Icosapent ethyl—Chills—Pravastatin—atherosclerosis	0.00142	0.00354	CcSEcCtD
Icosapent ethyl—Insomnia—Rosuvastatin—atherosclerosis	0.00142	0.00354	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00142	0.00249	CbGpPWpGaD
Icosapent ethyl—Ill-defined disorder—Simvastatin—atherosclerosis	0.00142	0.00352	CcSEcCtD
Icosapent ethyl—Arrhythmia—Pravastatin—atherosclerosis	0.00142	0.00352	CcSEcCtD
Icosapent ethyl—Malnutrition—Niacin—atherosclerosis	0.0014	0.00349	CcSEcCtD
Icosapent ethyl—Alopecia—Pravastatin—atherosclerosis	0.0014	0.00349	CcSEcCtD
Icosapent ethyl—Cough—Ezetimibe—atherosclerosis	0.0014	0.00348	CcSEcCtD
Icosapent ethyl—Arthralgia—Lovastatin—atherosclerosis	0.00139	0.00346	CcSEcCtD
Icosapent ethyl—Chest pain—Lovastatin—atherosclerosis	0.00139	0.00346	CcSEcCtD
Icosapent ethyl—Myalgia—Lovastatin—atherosclerosis	0.00139	0.00346	CcSEcCtD
Icosapent ethyl—Dyspepsia—Rosuvastatin—atherosclerosis	0.00139	0.00344	CcSEcCtD
Icosapent ethyl—Hypertension—Ezetimibe—atherosclerosis	0.00138	0.00344	CcSEcCtD
Icosapent ethyl—Malaise—Simvastatin—atherosclerosis	0.00138	0.00343	CcSEcCtD
Icosapent ethyl—Discomfort—Lovastatin—atherosclerosis	0.00137	0.00342	CcSEcCtD
Icosapent ethyl—Vertigo—Simvastatin—atherosclerosis	0.00137	0.00341	CcSEcCtD
Icosapent ethyl—Myalgia—Ezetimibe—atherosclerosis	0.00136	0.00339	CcSEcCtD
Icosapent ethyl—Chest pain—Ezetimibe—atherosclerosis	0.00136	0.00339	CcSEcCtD
Icosapent ethyl—Arthralgia—Ezetimibe—atherosclerosis	0.00136	0.00339	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00136	0.00239	CbGpPWpGaD
Icosapent ethyl—Dry mouth—Lovastatin—atherosclerosis	0.00136	0.00338	CcSEcCtD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—atherosclerosis	0.00136	0.068	CrCbGaD
Icosapent ethyl—Dysgeusia—Pravastatin—atherosclerosis	0.00135	0.00336	CcSEcCtD
Icosapent ethyl—Discomfort—Ezetimibe—atherosclerosis	0.00135	0.00335	CcSEcCtD
Icosapent ethyl—Constipation—Rosuvastatin—atherosclerosis	0.00135	0.00334	CcSEcCtD
Icosapent ethyl—Pain—Rosuvastatin—atherosclerosis	0.00135	0.00334	CcSEcCtD
Icosapent ethyl—Dry mouth—Ezetimibe—atherosclerosis	0.00133	0.00332	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Lovastatin—atherosclerosis	0.00133	0.00331	CcSEcCtD
Icosapent ethyl—Infection—Lovastatin—atherosclerosis	0.00133	0.00329	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00131	0.0023	CbGpPWpGaD
Icosapent ethyl—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00131	0.00325	CcSEcCtD
Icosapent ethyl—Arthralgia—Simvastatin—atherosclerosis	0.0013	0.00323	CcSEcCtD
Icosapent ethyl—Chest pain—Simvastatin—atherosclerosis	0.0013	0.00323	CcSEcCtD
Icosapent ethyl—Myalgia—Simvastatin—atherosclerosis	0.0013	0.00323	CcSEcCtD
Icosapent ethyl—Infection—Ezetimibe—atherosclerosis	0.0013	0.00323	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0013	0.00322	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—LDLRAP1—atherosclerosis	0.00129	0.00227	CbGpPWpGaD
Icosapent ethyl—Discomfort—Simvastatin—atherosclerosis	0.00129	0.0032	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Pravastatin—atherosclerosis	0.00128	0.00319	CcSEcCtD
Icosapent ethyl—Anorexia—Lovastatin—atherosclerosis	0.00127	0.00316	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00127	0.00222	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—atherosclerosis	0.00126	0.00222	CbGpPWpGaD
Icosapent ethyl—Vertigo—Niacin—atherosclerosis	0.00126	0.00313	CcSEcCtD
Icosapent ethyl—Syncope—Niacin—atherosclerosis	0.00126	0.00313	CcSEcCtD
Icosapent ethyl—Oedema—Simvastatin—atherosclerosis	0.00125	0.0031	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Simvastatin—atherosclerosis	0.00125	0.0031	CcSEcCtD
Icosapent ethyl—Malaise—Pravastatin—atherosclerosis	0.00125	0.0031	CcSEcCtD
Icosapent ethyl—Vertigo—Pravastatin—atherosclerosis	0.00124	0.00309	CcSEcCtD
Icosapent ethyl—Infection—Simvastatin—atherosclerosis	0.00124	0.00308	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Niacin—atherosclerosis	0.00123	0.00307	CcSEcCtD
Icosapent ethyl—Cough—Niacin—atherosclerosis	0.00122	0.00304	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PLTP—atherosclerosis	0.00122	0.00214	CbGpPWpGaD
Icosapent ethyl—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00122	0.00302	CcSEcCtD
Icosapent ethyl—Insomnia—Lovastatin—atherosclerosis	0.00121	0.003	CcSEcCtD
Icosapent ethyl—Cough—Pravastatin—atherosclerosis	0.00121	0.003	CcSEcCtD
Icosapent ethyl—Myalgia—Niacin—atherosclerosis	0.00119	0.00297	CcSEcCtD
Icosapent ethyl—Arthralgia—Niacin—atherosclerosis	0.00119	0.00297	CcSEcCtD
Icosapent ethyl—Hypertension—Pravastatin—atherosclerosis	0.00119	0.00297	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00119	0.00296	CcSEcCtD
Icosapent ethyl—Anorexia—Simvastatin—atherosclerosis	0.00119	0.00296	CcSEcCtD
Icosapent ethyl—Dyspnoea—Lovastatin—atherosclerosis	0.00119	0.00296	CcSEcCtD
Icosapent ethyl—Insomnia—Ezetimibe—atherosclerosis	0.00118	0.00294	CcSEcCtD
Icosapent ethyl—Arthralgia—Pravastatin—atherosclerosis	0.00118	0.00292	CcSEcCtD
Icosapent ethyl—Myalgia—Pravastatin—atherosclerosis	0.00118	0.00292	CcSEcCtD
Icosapent ethyl—Chest pain—Pravastatin—atherosclerosis	0.00118	0.00292	CcSEcCtD
Icosapent ethyl—Dyspepsia—Lovastatin—atherosclerosis	0.00117	0.00292	CcSEcCtD
Icosapent ethyl—Dry mouth—Niacin—atherosclerosis	0.00117	0.0029	CcSEcCtD
Icosapent ethyl—Dyspnoea—Ezetimibe—atherosclerosis	0.00117	0.0029	CcSEcCtD
Icosapent ethyl—Discomfort—Pravastatin—atherosclerosis	0.00116	0.00289	CcSEcCtD
Icosapent ethyl—Decreased appetite—Lovastatin—atherosclerosis	0.00116	0.00288	CcSEcCtD
Icosapent ethyl—Dyspepsia—Ezetimibe—atherosclerosis	0.00115	0.00286	CcSEcCtD
Icosapent ethyl—Oedema—Niacin—atherosclerosis	0.00115	0.00285	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Niacin—atherosclerosis	0.00115	0.00285	CcSEcCtD
Icosapent ethyl—Pain—Lovastatin—atherosclerosis	0.00114	0.00283	CcSEcCtD
Icosapent ethyl—Constipation—Lovastatin—atherosclerosis	0.00114	0.00283	CcSEcCtD
Icosapent ethyl—Decreased appetite—Ezetimibe—atherosclerosis	0.00114	0.00283	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00114	0.00282	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00113	0.00281	CcSEcCtD
Icosapent ethyl—Asthenia—Rosuvastatin—atherosclerosis	0.00113	0.00281	CcSEcCtD
Icosapent ethyl—Insomnia—Simvastatin—atherosclerosis	0.00113	0.0028	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00113	0.00198	CbGpPWpGaD
Icosapent ethyl—Anaphylactic shock—Pravastatin—atherosclerosis	0.00113	0.0028	CcSEcCtD
Icosapent ethyl—Oedema—Pravastatin—atherosclerosis	0.00113	0.0028	CcSEcCtD
Icosapent ethyl—Shock—Niacin—atherosclerosis	0.00113	0.0028	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00112	0.00197	CbGpPWpGaD
Icosapent ethyl—Infection—Pravastatin—atherosclerosis	0.00112	0.00278	CcSEcCtD
Icosapent ethyl—Pain—Ezetimibe—atherosclerosis	0.00112	0.00278	CcSEcCtD
Icosapent ethyl—Constipation—Ezetimibe—atherosclerosis	0.00112	0.00278	CcSEcCtD
Icosapent ethyl—Tachycardia—Niacin—atherosclerosis	0.00112	0.00278	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00111	0.00196	CbGpPWpGaD
Icosapent ethyl—Pruritus—Rosuvastatin—atherosclerosis	0.00111	0.00277	CcSEcCtD
Icosapent ethyl—Dyspnoea—Simvastatin—atherosclerosis	0.00111	0.00276	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Niacin—atherosclerosis	0.00111	0.00275	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Lovastatin—atherosclerosis	0.0011	0.00273	CcSEcCtD
Icosapent ethyl—Dyspepsia—Simvastatin—atherosclerosis	0.0011	0.00273	CcSEcCtD
Icosapent ethyl—Anorexia—Niacin—atherosclerosis	0.00109	0.00271	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Pravastatin—atherosclerosis	0.00109	0.00271	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.00109	0.00191	CbGpPWpGaD
Icosapent ethyl—Decreased appetite—Simvastatin—atherosclerosis	0.00108	0.0027	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Ezetimibe—atherosclerosis	0.00108	0.00268	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00108	0.00268	CcSEcCtD
Icosapent ethyl—Anorexia—Pravastatin—atherosclerosis	0.00108	0.00267	CcSEcCtD
Icosapent ethyl—Constipation—Simvastatin—atherosclerosis	0.00107	0.00265	CcSEcCtD
Icosapent ethyl—Pain—Simvastatin—atherosclerosis	0.00107	0.00265	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS2—atherosclerosis	0.00107	0.0534	CrCbGaD
Icosapent ethyl—DGAT1—Metabolism—LTA4H—atherosclerosis	0.00106	0.00185	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCG8—atherosclerosis	0.00106	0.00185	CbGpPWpGaD
Icosapent ethyl—Body temperature increased—Lovastatin—atherosclerosis	0.00105	0.00262	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00104	0.00259	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00104	0.00183	CbGpPWpGaD
Icosapent ethyl—Dizziness—Rosuvastatin—atherosclerosis	0.00104	0.00259	CcSEcCtD
Icosapent ethyl—Insomnia—Niacin—atherosclerosis	0.00104	0.00257	CcSEcCtD
Icosapent ethyl—Body temperature increased—Ezetimibe—atherosclerosis	0.00103	0.00257	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Simvastatin—atherosclerosis	0.00103	0.00256	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00103	0.00255	CcSEcCtD
Icosapent ethyl—Dyspnoea—Niacin—atherosclerosis	0.00102	0.00254	CcSEcCtD
Icosapent ethyl—Insomnia—Pravastatin—atherosclerosis	0.00102	0.00254	CcSEcCtD
Icosapent ethyl—Dyspepsia—Niacin—atherosclerosis	0.00101	0.00251	CcSEcCtD
Icosapent ethyl—Dyspnoea—Pravastatin—atherosclerosis	0.00101	0.0025	CcSEcCtD
Icosapent ethyl—Decreased appetite—Niacin—atherosclerosis	0.000996	0.00247	CcSEcCtD
Icosapent ethyl—Dyspepsia—Pravastatin—atherosclerosis	0.000993	0.00247	CcSEcCtD
Icosapent ethyl—Rash—Rosuvastatin—atherosclerosis	0.000992	0.00247	CcSEcCtD
Icosapent ethyl—Dermatitis—Rosuvastatin—atherosclerosis	0.000991	0.00246	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Niacin—atherosclerosis	0.000989	0.00246	CcSEcCtD
Icosapent ethyl—Body temperature increased—Simvastatin—atherosclerosis	0.000986	0.00245	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000984	0.00173	CbGpPWpGaD
Icosapent ethyl—Decreased appetite—Pravastatin—atherosclerosis	0.00098	0.00244	CcSEcCtD
Icosapent ethyl—Pain—Niacin—atherosclerosis	0.00098	0.00243	CcSEcCtD
Icosapent ethyl—Constipation—Pravastatin—atherosclerosis	0.000965	0.0024	CcSEcCtD
Icosapent ethyl—Pain—Pravastatin—atherosclerosis	0.000965	0.0024	CcSEcCtD
Icosapent ethyl—Asthenia—Lovastatin—atherosclerosis	0.000957	0.00238	CcSEcCtD
Icosapent ethyl—Pruritus—Lovastatin—atherosclerosis	0.000944	0.00235	CcSEcCtD
Icosapent ethyl—Asthenia—Ezetimibe—atherosclerosis	0.000939	0.00233	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Pravastatin—atherosclerosis	0.000929	0.00231	CcSEcCtD
Icosapent ethyl—Pruritus—Ezetimibe—atherosclerosis	0.000926	0.0023	CcSEcCtD
Icosapent ethyl—Body temperature increased—Niacin—atherosclerosis	0.000906	0.00225	CcSEcCtD
Icosapent ethyl—Asthenia—Simvastatin—atherosclerosis	0.000895	0.00222	CcSEcCtD
Icosapent ethyl—Body temperature increased—Pravastatin—atherosclerosis	0.000892	0.00222	CcSEcCtD
Icosapent ethyl—Pruritus—Simvastatin—atherosclerosis	0.000883	0.00219	CcSEcCtD
Icosapent ethyl—Dizziness—Lovastatin—atherosclerosis	0.000882	0.00219	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000877	0.00154	CbGpPWpGaD
Icosapent ethyl—Dizziness—Ezetimibe—atherosclerosis	0.000865	0.00215	CcSEcCtD
Icosapent ethyl—Vomiting—Lovastatin—atherosclerosis	0.000848	0.00211	CcSEcCtD
Icosapent ethyl—Rash—Lovastatin—atherosclerosis	0.000841	0.00209	CcSEcCtD
Icosapent ethyl—Dermatitis—Lovastatin—atherosclerosis	0.00084	0.00209	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—ABCG1—atherosclerosis	0.000834	0.00147	CbGpPWpGaD
Icosapent ethyl—Vomiting—Ezetimibe—atherosclerosis	0.000832	0.00207	CcSEcCtD
Icosapent ethyl—Dizziness—Simvastatin—atherosclerosis	0.000825	0.00205	CcSEcCtD
Icosapent ethyl—Rash—Ezetimibe—atherosclerosis	0.000825	0.00205	CcSEcCtD
Icosapent ethyl—Dermatitis—Ezetimibe—atherosclerosis	0.000824	0.00205	CcSEcCtD
Icosapent ethyl—Asthenia—Niacin—atherosclerosis	0.000822	0.00204	CcSEcCtD
Icosapent ethyl—Pruritus—Niacin—atherosclerosis	0.00081	0.00201	CcSEcCtD
Icosapent ethyl—Asthenia—Pravastatin—atherosclerosis	0.000809	0.00201	CcSEcCtD
Icosapent ethyl—Pruritus—Pravastatin—atherosclerosis	0.000798	0.00198	CcSEcCtD
Icosapent ethyl—Vomiting—Simvastatin—atherosclerosis	0.000793	0.00197	CcSEcCtD
Icosapent ethyl—Rash—Simvastatin—atherosclerosis	0.000787	0.00195	CcSEcCtD
Icosapent ethyl—Dermatitis—Simvastatin—atherosclerosis	0.000786	0.00195	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—FABP4—atherosclerosis	0.000784	0.00138	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LCAT—atherosclerosis	0.000784	0.00138	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOA4—atherosclerosis	0.00077	0.00135	CbGpPWpGaD
Icosapent ethyl—Dizziness—Niacin—atherosclerosis	0.000758	0.00188	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYP7A1—atherosclerosis	0.000756	0.00133	CbGpPWpGaD
Icosapent ethyl—Dizziness—Pravastatin—atherosclerosis	0.000746	0.00185	CcSEcCtD
Icosapent ethyl—Vomiting—Niacin—atherosclerosis	0.000728	0.00181	CcSEcCtD
Icosapent ethyl—Rash—Niacin—atherosclerosis	0.000722	0.0018	CcSEcCtD
Icosapent ethyl—Dermatitis—Niacin—atherosclerosis	0.000722	0.00179	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000721	0.00127	CbGpPWpGaD
Icosapent ethyl—Vomiting—Pravastatin—atherosclerosis	0.000717	0.00178	CcSEcCtD
Icosapent ethyl—Rash—Pravastatin—atherosclerosis	0.000711	0.00177	CcSEcCtD
Icosapent ethyl—Dermatitis—Pravastatin—atherosclerosis	0.000711	0.00177	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—CYP27A1—atherosclerosis	0.000699	0.00123	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000688	0.00121	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000672	0.00118	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLA2G2A—atherosclerosis	0.000663	0.00116	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOA2—atherosclerosis	0.000663	0.00116	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALOX5AP—atherosclerosis	0.000663	0.00116	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALOX15—atherosclerosis	0.000663	0.00116	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCG5—atherosclerosis	0.000655	0.00115	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000654	0.00115	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LPA—atherosclerosis	0.000632	0.00111	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—BGN—atherosclerosis	0.000612	0.00108	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000608	0.00107	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOA5—atherosclerosis	0.000606	0.00106	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000589	0.00103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PLA2G1B—atherosclerosis	0.000584	0.00102	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000577	0.00101	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000572	0.001	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.00057	0.001	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALOX5—atherosclerosis	0.000564	0.00099	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000521	0.000915	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NAMPT—atherosclerosis	0.000505	0.000888	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000503	0.000883	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LIPC—atherosclerosis	0.000502	0.000882	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOC3—atherosclerosis	0.000499	0.000877	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LDLR—atherosclerosis	0.000496	0.000871	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CETP—atherosclerosis	0.000485	0.000851	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SCARB1—atherosclerosis	0.000464	0.000815	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000452	0.000794	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HMGCR—atherosclerosis	0.000438	0.00077	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000395	0.000694	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCA1—atherosclerosis	0.000391	0.000686	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HMOX1—atherosclerosis	0.000335	0.000589	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOB—atherosclerosis	0.000321	0.000564	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTM1—atherosclerosis	0.000312	0.000549	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—LPL—atherosclerosis	0.000307	0.000538	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPX1—atherosclerosis	0.000299	0.000525	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CD36—atherosclerosis	0.000291	0.000512	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTHFR—atherosclerosis	0.000276	0.000485	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPARA—atherosclerosis	0.000271	0.000476	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AGT—atherosclerosis	0.000262	0.000461	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOE—atherosclerosis	0.000257	0.000451	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CAV1—atherosclerosis	0.000255	0.000447	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—APOA1—atherosclerosis	0.000254	0.000446	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CG—atherosclerosis	0.000232	0.000407	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PPARG—atherosclerosis	0.000224	0.000393	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—INS—atherosclerosis	0.00022	0.000386	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALB—atherosclerosis	0.000201	0.000353	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NOS3—atherosclerosis	0.000192	0.000338	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—atherosclerosis	0.000176	0.000309	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AKT1—atherosclerosis	8.85e-05	0.000155	CbGpPWpGaD
